CLBCX
Price
$40.77
Change
-$0.02 (-0.05%)
Updated
Jul 10 closing price
Net Assets
288.09B
FFAMX
Price
$23.43
Change
-$0.08 (-0.34%)
Updated
Jul 10 closing price
Net Assets
10.93B
Interact to see
Advertisement

CLBCX vs FFAMX

CLBCX vs FFAMX Comparison Chart in %
View a ticker or compare two or three
VS
CLBCX vs. FFAMX commentary
Jul 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and FFAMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 288B vs. FFAMX (10.9B). FFAMX pays higher dividends than CLBCX: FFAMX (1.90) vs CLBCX (1.07). CLBCX was incepted earlier than FFAMX: CLBCX (24 years) vs FFAMX (20 years). CLBCX (1.35) is less costly to investors than FFAMX (0.85). CLBCX is a more actively managed with annual turnover of: 50.00 vs. FFAMX (25.00). FFAMX has a lower initial minimum investment than CLBCX: FFAMX (0) vs CLBCX (250). CLBCX annual gain was more profitable for investors over the last year : 11.70 vs. FFAMX (10.51). CLBCX return over 5 years is better than : 30.78 vs. FFAMX (16.79).
CLBCXFFAMXCLBCX / FFAMX
Total Expense Ratio1.350.82165%
Annual Report Gross Expense Ratio1.350.85159%
Fund Existence24 years20 years-
Gain YTD8.9858.672104%
Front LoadN/A6%-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets288B10.9B2,642%
Annual Yield % from dividends1.071.9056%
Returns for 1 year11.7010.51111%
Returns for 3 years39.4333.23119%
Returns for 5 years30.7816.79183%
Returns for 10 years80.2261.25131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFAFX18.070.14
+0.78%
Hartford Schroders Intl Cntrrn Val R5
GLBIX10.760.04
+0.37%
Leuthold Global Institutional
BRWVX30.040.11
+0.37%
MFS Blended Research Growth Eq R6
MIDHX34.070.12
+0.35%
MFS International New Discovery R3
LGOAX54.250.06
+0.11%
Patient Opportunity A